BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 239732)

  • 1. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part.
    Kaku T; Miyata T; Uruno T; Sako I; Kinoshita A
    Arzneimittelforschung; 1975 Apr; 25(4):539-47. PubMed ID: 239732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies of Panax ginseng root: estimation of pharmacological actions of Panax ginseng root.
    Takagi K; Saito H; Nabata H
    Jpn J Pharmacol; 1972 Apr; 22(2):245-9. PubMed ID: 4538416
    [No Abstract]   [Full Text] [Related]  

  • 3. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo radioprotective effect of Panax ginseng C.A. Meyer and identification of active ginsenosides.
    Lee HJ; Kim SR; Kim JC; Kang CM; Lee YS; Jo SK; Kim TH; Jang JS; Nah SY; Kim SH
    Phytother Res; 2006 May; 20(5):392-5. PubMed ID: 16619368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies of neutral saponins (GNS) of Panax Ginseng root.
    Nabata H; Saito H; Takagi K
    Jpn J Pharmacol; 1973 Feb; 23(1):29-41. PubMed ID: 4541616
    [No Abstract]   [Full Text] [Related]  

  • 12. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice.
    Sun J; Hu S; Song X
    Vaccine; 2007 Jan; 25(6):1114-20. PubMed ID: 17069940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological studies on oxatomide: (6) Effect on the peripheral organs].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):79-104. PubMed ID: 6133821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
    Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. I. Chemical part.
    Kaku T; Miyata T; Uruno T; Sako I; Kinoshita A
    Arzneimittelforschung; 1975 Mar; 25(3):343-7. PubMed ID: 1174030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng.
    Sun HX; Qin F; Ye YP
    Vaccine; 2005 Dec; 23(48-49):5533-42. PubMed ID: 16115706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part I. General pharmacological properties.
    Ernest K
    Pol J Pharmacol Pharm; 1975; 27(4):363-79. PubMed ID: 241067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological properties of lopramine].
    Akashi A; Hashizume T; Tanaka M; Naka S; Suzuki I
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):417-31. PubMed ID: 987974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.